Metraipolis › archive › dc_08a3f539d656

Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant… — Europe PMC PMID:42569093

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42569093
DOI
10.1155/aiu/2359934
License (as archived)
solo-consultazione
Archived
2026-11-05T08:08:59.537Z
SHA-256 of the archived text
4950edbba4291d51d689df081799ab7a6aa9c580db6020e7cbffb1a87149e5ab
Stable URL of this page
https://metraipolis.com/documento/dc_08a3f539d656

How to cite

Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant… — Europe PMC PMID:42569093 — Europe PMC (en), https://europepmc.org/article/MED/42569093 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08a3f539d656 (Metraipolis archive dc_08a3f539d656, sha256 4950edbba4291d51d689df081799ab7a6aa9c580db6020e7cbffb1a87149e5ab)
BibTeX
@misc{dc08a3f539d656,
  title = {Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant… — Europe PMC PMID:42569093},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42569093},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08a3f539d656; sha256 4950edbba4291d51d689df081799ab7a6aa9c580db6020e7cbffb1a87149e5ab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42569093. Agents can read the archived copy with the MCP tool read_document.